Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cern lhc coll (710) 710
experimental results (702) 702
experiment (698) 698
physics (656) 656
high energy physics - experiment (628) 628
particle physics (618) 618
physics - high energy physics - experiment (556) 556
p p: scattering (547) 547
cms (536) 536
high energy physics (502) 502
p p: colliding beams (489) 489
13000 gev-cms (367) 367
physics of elementary particles and fields (346) 346
phenomenology (334) 334
scattering [p p] (252) 252
particle physics - experiment (244) 244
hep (226) 226
colliding beams [p p] (214) 214
8000 gev-cms (212) 212
nuclear experiment (207) 207
background (200) 200
hadron-hadron scattering (192) 192
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (145) 145
ex (120) 120
supersymmetry (114) 114
transverse momentum: missing-energy (114) 114
channel cross section: upper limit (107) 107
cern lab (106) 106
physics, particles & fields (104) 104
mass dependence (98) 98
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (97) 97
final state:jet lepton (94) 94
astrophysics (89) 89
transverse momentum dependence (86) 86
elementary particles, quantum field theory (79) 79
quantum field theories, string theory (79) 79
data analysis method (78) 78
top: pair production (78) 78
kinematics (77) 77
bottom: particle identification (76) 76
jet: bottom (75) 75
rapidity dependence (74) 74
high energy astrophysical phenomena (71) 71
z0: leptonic decay (71) 71
classical and quantum gravitation, relativity theory (69) 69
quantum physics (69) 69
channel cross section: branching ratio: upper limit (67) 67
muon: pair production (67) 67
higgs particle: hadroproduction (66) 66
nuclear physics (66) 66
114 physical sciences (64) 64
astronomy & astrophysics (62) 62
final state:jet dilepton (62) 62
quantum chromodynamics: perturbation theory (62) 62
channel cross section: measured (59) 59
mass spectrum: (55) 55
nuclear and high energy physics (55) 55
jet: transverse momentum (54) 54
instrumentation and detectors (52) 52
differential cross section: measured (51) 51
electroweak interaction (50) 50
lead (50) 50
bottom: pair production (49) 49
transverse momentum (49) 49
new physics: search for (48) 48
squark: pair production (47) 47
w: leptonic decay (47) 47
beyond standard model (46) 46
mass: lower limit (46) 46
sensitivity (45) 45
upper limit [channel cross section] (45) 45
jet lepton (44) 44
jet: multiplicity (44) 44
final state:jet (43) 43
missing-energy [transverse momentum] (42) 42
numerical calculations: monte carlo (42) 42
physics and astronomy (42) 42
physics, nuclear (42) 42
gravitation (40) 40
higgs particle: hadronic decay (40) 40
higher-order: 1 (40) 40
narrow resonance (40) 40
rapidity (40) 40
z0: associated production (40) 40
collisions (39) 39
signature (38) 38
structure (38) 38
tau: pair production (38) 38
7000 gev-cms (36) 36
dijet (36) 36
hep-ex (36) 36
pair production [top] (36) 36
resonance: production (36) 36
stop: mass: lower limit (35) 35
large hadron collider (34) 34
phase space (34) 34
transverse momentum [jet] (34) 34
bottom [jet] (33) 33
higgs physics (33) 33
gluino: pair production (32) 32
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
by Ferreri, Andrés JM, Dr and Reni, Michele, MD and Foppoli, Marco, MD and Martelli, Maurizio, MD and Pangalis, Gerasimus A, MD and Frezzato, Maurizio, MD and Cabras, Maria Giuseppina, MD and Fabbri, Alberto, MD and Corazzelli, Gaetano, MD and Ilariucci, Fiorella, MD and Rossi, Giuseppe, MD and Soffietti, Riccardo, MD and Stelitano, Caterina, MD and Vallisa, Daniele, MD and Zaja, Francesco, MD and Zoppegno, Lucía, MD and Aondio, Gian Marco, MD and Avvisati, Giuseppe, MD and Balzarotti, Monica, MD and Brandes, Alba A, MD and Fajardo, José, MD and Gomez, Henry, MD and Guarini, Attilio, MD and Pinotti, Graziella, MD and Rigacci, Luigi, MD and Uhlmann, Catrina, MD and Picozzi, Piero, MD and Vezzulli, Paolo, MD and Ponzoni, Maurilio, MD and Zucca, Emanuele, MD and Caligaris-Cappio, Federico, MD and Cavalli, Franco, MD and IELSG and International Extranodal Lymphoma Study Group (IELSG)
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9700, pp. 1512 - 1520
Summary Background Chemotherapy with high-dose methotrexate is the conventional approach to treat primary CNS lymphomas, but superiority of polychemotherapy... 
Internal Medicine | DEFERRED RADIOTHERAPY | MEDICINE, GENERAL & INTERNAL | B-CELL LYMPHOMA | INTERNATIONAL WORKSHOP | RESPONSE CRITERIA | EUROPEAN ORGANIZATION | CONSOLIDATING RADIOTHERAPY | NON-HODGKINS-LYMPHOMA | INITIAL TREATMENT | CENTRAL-NERVOUS-SYSTEM | CEREBROSPINAL-FLUID | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Lymphoma, Non-Hodgkin - radiotherapy | Cranial Irradiation - methods | Central Nervous System Neoplasms - radiotherapy | Adult | Lymphoma, Non-Hodgkin - drug therapy | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Combined Modality Therapy | Remission Induction | Methotrexate - adverse effects | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Aged | Lymphoma, Non-Hodgkin - mortality | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Cytarabine | Patient outcomes | Central nervous system diseases | Dosage and administration | Lymphomas | Drug therapy, Combination | Methotrexate | Drug therapy | Data analysis | Disease | Monoclonal antibodies | Data collection | Radiation therapy | Patients | Tropical diseases | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text The Lugano classification criteria are useful in primary mediastinal B-cell lymphoma. In reply to Adams and Kwee
by Ceriani, Luca, MD and Johnson, Peter W.M., MD and Martelli, Maurizio, MD and Zucca, Emanuele, MD
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016
Radiology | Hematology, Oncology and Palliative Medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial
by Garassino, Marina Chiara, MD and Martelli, Olga, MD and Broggini, Massimo, PhD and Farina, Gabriella, MD and Veronese, Silvio, PhD and Rulli, Eliana, PhD and Bianchi, Filippo, MD and Bettini, Anna, MD and Longo, Flavia, MD and Moscetti, Luca, MD and Tomirotti, Maurizio, MD and Marabese, Mirko, PhD and Ganzinelli, Monica, PhD and Lauricella, Calogero, PhD and Labianca, Roberto, MD and Floriani, Irene, PhD and Giaccone, Giuseppe, MD and Torri, Valter, MD and Scanni, Alberto, MD and Marsoni, Silvia, MD and TAILOR Trialists and TAILOR trialists
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 10, pp. 981 - 988
Summary Background Erlotinib is registered for treatment of all patients with advanced non-small-cell lung cancer (NSCLC). However, its efficacy for treatment... 
Hematology, Oncology and Palliative Medicine | PHASE-III TRIAL | SURVIVAL | GEFITINIB | MULTICENTER | ONCOLOGY | FACTOR RECEPTOR MUTATIONS | CLINICAL-TRIALS | PLATINUM-BASED CHEMOTHERAPY | DOUBLE-BLIND | PROGRESSION-FREE | OPEN-LABEL | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Proto-Oncogene Proteins - genetics | Antineoplastic Agents - therapeutic use | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Taxoids - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Aged, 80 and over | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Adult | Female | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Care and treatment | Chemotherapy | Erlotinib | Clinical trials | Lung cancer, Non-small cell | Tumors | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
by Klionsky, Daniel J and Abdelmohsen, Kotb and Abe, Akihisa and Abedin, Md Joynal and Abeliovich, Hagai and Acevedo Arozena, Abraham and Adachi, Hiroaki and Adams, Christopher M and Adams, Peter D and Adeli, Khosrow and Adhihetty, Peter J and Adler, Sharon G and Agam, Galila and Agarwal, Rajesh and Aghi, Manish K and Agnello, Maria and Agostinis, Patrizia and Aguilar, Patricia V and Aguirre-Ghiso, Julio and Airoldi, Edoardo M and Ait-Si-Ali, Slimane and Akematsu, Takahiko and Akporiaye, Emmanuel T and Al-Rubeai, Mohamed and Albaiceta, Guillermo M and Albanese, Chris and Albani, Diego and Albert, Matthew L and Aldudo, Jesus and Algül, Hana and Alirezaei, Mehrdad and Alloza, Iraide and Almasan, Alexandru and Almonte-Beceril, Maylin and Alnemri, Emad S and Alonso, Covadonga and Altan-Bonnet, Nihal and Altieri, Dario C and Alvarez, Silvia and Alvarez-Erviti, Lydia and Alves, Sandro and Amadoro, Giuseppina and Amano, Atsuo and Amantini, Consuelo and Ambrosio, Santiago and Amelio, Ivano and Amer, Amal O and Amessou, Mohamed and Amon, Angelika and An, Zhenyi and Anania, Frank A and Andersen, Stig U and Andley, Usha P and Andreadi, Catherine K and Andrieu-Abadie, Nathalie and Anel, Alberto and Ann, David K and Anoopkumar-Dukie, Shailendra and Antonioli, Manuela and Aoki, Hiroshi and Apostolova, Nadezda and Aquila, Saveria and Aquilano, Katia and Araki, Koichi and Arama, Eli and Aranda, Agustin and Araya, Jun and Arcaro, Alexandre and Arias, Esperanza and Arimoto, Hirokazu and Ariosa, Aileen R and Armstrong, Jane L and Arnould, Thierry and Arsov, Ivica and Asanuma, Katsuhiko and Askanas, Valerie and Asselin, Eric and Atarashi, Ryuichiro and Atherton, Sally S and Atkin, Julie D and Attardi, Laura D and Auberger, Patrick and Auburger, Georg and Aurelian, Laure and Autelli, Riccardo and Avagliano, Laura and Avantaggiati, Maria Laura and Avrahami, Limor and Awale, Suresh and Azad, Neelam and Bachetti, Tiziana and Backer, Jonathan M and Bae, Dong-Hun and Bae, Jae-sung and Bae, Ok-Nam and Bae, Soo Han and Baehrecke, Eric H and Baek, Seung-Hoon and Baghdiguian, Stephen and Bagniewska-Zadworna, Agnieszka and ... and Medicinska fakulteten and Region Östergötland and Linköpings universitet and Institutionen för klinisk och experimentell medicin and Diagnostikcentrum and Klinisk patologi och klinisk genetik and Institutionen för medicin och hälsa and Avdelningen för läkemedelsforskning and Avdelningen för cellbiologi
Autophagy, ISSN 1554-8627, 01/2016, Volume 12, Issue 1, pp. 1 - 222
stress | chaperone-mediated autophagy | vacuole | autolysosome | macroautophagy | flux | autophagosome | LC3 | lysosome | phagophore | Phagophore | Lysosome | Autolysosome | Flux | Autophagosome | Vacuole | Chaperonemediated autophagy | Macroautophagy | Stress | ACTIVATED PROTEIN-KINASE | ENDOPLASMIC-RETICULUM STRESS | STARVATION-INDUCED AUTOPHAGY | GLUCAGON-INDUCED AUTOPHAGY | CELL BIOLOGY | PROGRAMMED CELL-DEATH | LIFE-SPAN EXTENSION | BETAINE HOMOCYSTEINE METHYLTRANSFERASE | VACUOLAR MEMBRANE DYNAMICS | NF-KAPPA-B | Autophagy - physiology | Biological Assay - methods | Animals | Biological Assay - standards | Computer Simulation | Humans | Life Sciences | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Observation of a new boson at a mass of 125 GeV with the CMS experiment at the LHC
by Chatrchyan, S and Khachatryan, V and Sirunyan, A.M and Tumasyan, A and Adam, N and Adam, W and Aguilo, E and Bergauer, T and Dragicevic, M and Erö, J and Fabjan, C and Friedl, M and Frühwirth, R and Ghete, V.M and Hammer, J and Hoch, M and Hörmann, N and Hrubec, J and Jeitler, M and Kiesenhofer, W and Knünz, V and Krammer, M and Krätschmer, I and Liko, D and Majerotto, W and Mikulec, I and Pernicka, M and Rahbaran, B and Rohringer, H and Rohringer, C and Schöfbeck, R and Strauss, J and Szoncsó, F and Taurok, A and Waltenberger, W and Walzel, G and Widl, E and Wulz, C.-E and Chekhovsky, V and Emeliantchik, I and Litomin, A and Makarenko, V and Mossolov, V and Shumeiko, N and Solin, A and Stefanovitch, R and Suarez Gonzalez, J and Fedorov, A and Korzhik, M and Missevitch, O and Zuyeuski, R and Bansal, M and Bansal, S and Beaumont, W and Cornelis, T and De Wolf, E.A and Druzhkin, D and Janssen, X and Luyckx, S and Mucibello, L and Ochesanu, S and Roland, B and Roland, C and Roland, G and Rougny, R and Selvaggi, G and Selvaggi, M and Staykova, Z and Van Haevermaet, H and Van Mechelen, P and Van Remortel, N and Van Spilbeeck, A and Blekman, F and Blyweert, S and DʼHondt, J and Devroede, O and Gonzalez Suarez, R and Goorens, R and Kalogeropoulos, A and Maes, M and Olbrechts, A and Tavernier, S and Van Doninck, W and Van Lancker, L and Van Mulders, P and Van Onsem, G.P and Villella, I and Clerbaux, B and De Lentdecker, G and Dero, V and Dewulf, J.P and Gay, A.P.R and Hreus, T and Léonard, A and Marage, P.E and Mohammadi, A and Reis, T and Rugovac, S and Thomas, S and Thomas, M and ... and CMS Collaboration and Los Alamos National Lab. (LANL), Los Alamos, NM (United States) and Argonne National Lab. (ANL), Argonne, IL (United States) and Fermi National Accelerator Lab. (FNAL), Batavia, IL (United States) and Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States)
Physics Letters B, ISSN 0370-2693, 09/2012, Volume 716, Issue 1, pp. 30 - 61
Results are presented from searches for the standard model Higgs boson in proton–proton collisions at and 8 TeV in the Compact Muon Solenoid experiment at the... 
CMS | Higgs | Physics | PARTON DISTRIBUTIONS | SEARCH | PHYSICS, NUCLEAR | COLLIDERS | STANDARD MODEL | ELECTROWEAK CORRECTIONS | BROKEN SYMMETRIES | ASTRONOMY & ASTROPHYSICS | QCD CORRECTIONS | PP COLLISIONS | SPECTRUM | MODEL HIGGS-BOSON | PHYSICS, PARTICLES & FIELDS | Analysis | Collisions (Nuclear physics) | Searching | Elementary particles | Decay | Higgs bosons | Standard deviation | Solenoids | Standards | Bosons | Physics - High Energy Physics - Experiment | High Energy Physics - Experiment | PHYSICS OF ELEMENTARY PARTICLES AND FIELDS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights